These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 376703)
21. Immune response deficiency of BSVS mice. II. Generalized deficiency to thymus-dependent antigens. Briles DE; Perlmutter RM; Hansburg D; Little JR; Davie JM Eur J Immunol; 1979 Apr; 9(4):255-61. PubMed ID: 89033 [TBL] [Abstract][Full Text] [Related]
22. XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. Morse HC; Chused TM; Boehm-Truitt M; Mathieson BJ; Sharrow SO; Hartley JW J Immunol; 1979 Feb; 122(2):443-54. PubMed ID: 216748 [No Abstract] [Full Text] [Related]
23. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
24. The in vitro generation of H-2-restricted cytotoxic T cells to AKR/Gross leukemia virus-induced tumors. I. Requirement for stimulation with allogeneic leukemia cells in vivo. Green WR J Immunol; 1982 Mar; 128(3):1043-9. PubMed ID: 6976986 [No Abstract] [Full Text] [Related]
25. Regulation of immune response in allogeneic mixed spleen cell cultures. I. Influence of I-region on the generation of suppressor cells. Kim YT; Schwartz A; Moody C; Siskind GW; Weksler ME J Immunol; 1980 Oct; 125(4):1724-9. PubMed ID: 6447730 [TBL] [Abstract][Full Text] [Related]
26. Genetic control of the cytolytic T lymphocyte response to influenza viruses: H-2 genes influence the response to H-2Kb plus virus. Reiss CS; Dorf ME; Benacerraf B; Burakoff SJ J Immunol; 1982 May; 128(5):2295-9. PubMed ID: 6174627 [TBL] [Abstract][Full Text] [Related]
27. Mechanisms in T cell leukemogenesis. II. T cell responses of preleukemic BALB/c mice to Moloney leukemia virus antigens. Lee JC; Horak I; Ihle JN J Immunol; 1981 Feb; 126(2):715-22. PubMed ID: 6969759 [TBL] [Abstract][Full Text] [Related]
28. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control. Debre P; Gisselbrecht S; Boyer B; Levy JP Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141 [TBL] [Abstract][Full Text] [Related]
30. The relationship between tumor antigens and alloantigens: cross-reactivity due to differential context of T cell antigen recognition. Perry LL; Greene MI J Immunol; 1980 Aug; 125(2):738-48. PubMed ID: 6967088 [No Abstract] [Full Text] [Related]
31. Non-MHC-linked genetic control of murine cytotoxic T lymphocyte responses to hapten-modified syngeneic cells. Arora PK; Shearer GM J Immunol; 1981 Nov; 127(5):1822-8. PubMed ID: 6975299 [No Abstract] [Full Text] [Related]
32. Genetic control of sensitivity to Moloney leukemia virus in mice. II. Mapping of three resistant genes within the H-2 complex. Debre P; Gisselbrecht S; Pozo F; Levy JP J Immunol; 1979 Oct; 123(4):1806-12. PubMed ID: 479600 [TBL] [Abstract][Full Text] [Related]
33. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70. Stackpole CW; Cremona P; Leonard C; Stremmel P J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136 [No Abstract] [Full Text] [Related]
34. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. Flyer DC; Burakoff SJ; Faller DV J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792 [TBL] [Abstract][Full Text] [Related]
35. Anti-self receptors. II. Demonstration of H-2L region-restricted receptors on subpopulations of peripheral T and B lymphocytes. Sia DY; Parish CR J Immunol; 1980 May; 124(5):2366-72. PubMed ID: 6965970 [TBL] [Abstract][Full Text] [Related]
37. Shared chemical properties of different murine thymus-leukemia antigens. Pischel KD; Little JR J Immunol; 1979 May; 122(5):1821-7. PubMed ID: 448110 [TBL] [Abstract][Full Text] [Related]
38. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia. Schmidt W; Festenstein H; Atfield G Transplant Proc; 1980 Mar; 12(1):29-31. PubMed ID: 7368291 [No Abstract] [Full Text] [Related]
39. T cell recognition of Moloney sarcoma virus proteins during tumor regression. I. Lack of a requirement for macrophages and the role of blastogenic factors in T cell proliferation. Enjuanes L; Lee JC; Ihle JN J Immunol; 1981 Apr; 126(4):1478-84. PubMed ID: 6970777 [TBL] [Abstract][Full Text] [Related]
40. Genetic restrictions in the development of antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by nude mice implanted with semiallogeneic thymus glands. Lake JP; Kapp JA; Pierce CW J Immunol; 1986 Feb; 136(3):805-12. PubMed ID: 2934479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]